Successful, Independently-Reviewed, Published FDA-Regulated
IRB-Monitored Research Study

HairGenesis™ is the only Non-Drug (naturally-derived from herbal and botanical sources)
hair growth hair loss treatment with DHT Blockers backed by independent and published
FDA-Regulated research. It is clinically-proven to be safe and effective for both
men and women to help stop thinning hair, hairloss and regrow hair naturally.

Clinical Research

HairGenesis™ has been tested both in open-label clinical research studies as well as in a double-blind, placebo-controlled study.

HairGenesis™ was designed with the understanding that individual botanical substances have previously demonstrated real benefit against hormonal disorders that also cause pattern hair loss and baldness. In developing these oral and topical formulations, a regimen has been developed which is unique in design as well as effectiveness.

For those wishing to develop a deeper understanding of the details involved in this subject, we have provided a selection of relevant data supporting the safety and effectiveness of HairGenesis™ as observed within two open-label clinical studies.

HairGenesis™ Clinical Trials

Clinical Study 1 - Non-Randomized Uncontrolled Clinical Study to Determine the Efficacy of a New Treatment for Androgenetic Alopecia (AGA)

Clinical Study 2 - Non-Randomized Uncontrolled Follow Up Clinical Study to Determine the Efficacy of a New Treatment for Androgenetic Alopecia (AGA)

HairGenesis™ FDA-Regulated Research

In April 2002, The Journal of Alternative and Complementary Medicine, a highly esteemed medical journal, accepted for publication the entire research manuscript outlining the remarkable clinical trial results of HairGenesis™ products from an independent FDA-regulated IRB-monitored (Institutional Review Board) Peer-Reviewed, Placebo-Controlled, Double-Blind Clinical Study

"A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy and Safety of a Novel Formulation Comprised of Botanically Derived Inhibitors of 5AR in the Treatment of Androgenetic Alopecia" (5AR Inhibitors refers to DHT blockers.)

This independently conducted HairGenesis™ research study represents the first report of the successful use of a naturally derived hair loss treatment formulation against androgenetic alopecia (pattern hair loss). This clinical trial heralds a major paradigm shift in the standard clinical approaches in treating pattern hair loss, since it introduces HairGenesis™ as a safe and effective alternative to the pharmaceutically derived drugs Rogaine™ and Propecia™ (Proscar, Finasteride, Dudasteride). The research manuscript outlining this remarkable clinical trial was published within the April 2002 edition of the Journal of Alternative and Complementary Medicine. The published study manuscript is currently available in its entirety on this web site as a PDF download.

Please note that you must have Adobe Acrobat Reader
installed on your computer to read the Adobe PDF documents

 

For those wishing to develop a deeper understanding of the processes involved in pattern hair loss and baldness, we have also provided a selection of more detailed relevant research data covering important elements of hair growth and the disorders associated with hair loss. You can also download both of these reports by clicking on one of the Hair Loss links below:

1.) Hair Loss: Causes, Clinical Manifestations, And Available Treatments
2.) Androgen Disorders Related to Pattern Hair Loss

If you have a question of a medical or health-related nature regarding HairGenesis™ products or Hair Loss, please email the Research Department. Your questions will be reviewed and addressed by a research expert.